Teva launches generic version of EpiPen for young children
The drugmaker has been struggling with falling prices of generics and faces lawsuits that allege it helped fuel the U.S. opioid addiction epidemic.
A building belonging to generic drug producer Teva, Israel's largest company with a market value of about $57 billion, is seen in Jerusalem(photo credit: REUTERS/BAZ RATNER)